Health Policy

Function

The Working Group on Health Policy deals with business and political parameters, ranging from licensing, paths to reimbursement, market access and care to billing for biopharmaceutical products. More broadly, its work also involves analysing the business policy and health economy policy issues of the legal parameters for Germany as a biotech location.

Members

Co-ordinators

Prof. Dr. Helga Rübsamen-Schaeff AiCuris Anti-infective Cures GmbH
Prof. Dr. med. Niels Riedemann InflaRx GmbH

Experts from the following companies